Stein-Streilein Joan
Schepens Eye Research Institute, Harvard Medical School, Boston, MA 02114, USA.
Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):111-7. doi: 10.1080/09273940490912371.
The eye is an immune-privileged site that uses specialized mechanisms to protect itself from damage and to preserve its visual acuity. Among the mechanisms that contribute to the eye's privileged existence is its ability to induce both local and peripheral tolerance to antigens that may transgress its chambers. Experimentally, antigens that are inoculated into the anterior chamber induce an associated immune deviation of immune lymphocytes from their potential T-helper inflammatory responses to T regulatory cells. The prominent role of a somewhat rare cell called invariant (i)NKT cell in the process of tolerance induced through the anterior chamber-associated immune deviation model, ACAID, has revealed novel biological characteristics for the iNKT cell, as well as novel mechanisms for the induction of tolerance that have not been previously known or considered. The role of the iNKT cell in ACAID and its novel story is discussed in this mini-review.
眼睛是一个免疫赦免部位,它利用特殊机制保护自身免受损伤并维持视力。有助于眼睛获得这种特殊状态的机制之一是,它能够诱导对可能侵入其腔室的抗原产生局部和外周耐受。在实验中,接种到前房的抗原会诱导免疫淋巴细胞发生相关的免疫偏离,使其从潜在的T辅助炎症反应转向T调节细胞。一种相对罕见的细胞,即不变自然杀伤T细胞(iNKT细胞),在前房相关免疫偏离模型(ACAID)诱导的耐受过程中发挥着重要作用,这揭示了iNKT细胞的新生物学特性,以及此前未知或未被考虑的诱导耐受的新机制。本综述将讨论iNKT细胞在ACAID中的作用及其新发现。